Zobrazeno 1 - 10
of 302
pro vyhledávání: '"paliperidone palmitate 3-monthly"'
Autor:
Chiang, Chih‐Lin1 (AUTHOR), Chinen, Madoka2 (AUTHOR), Daskiran, Mehmet3 (AUTHOR), Wakamatsu, Akihide2 (AUTHOR), Turkoz, Ibrahim3 (AUTHOR) iturkoz@its.jnj.com
Publikováno v:
Neuropsychopharmacology Reports. Dec2024, Vol. 44 Issue 4, p716-727. 12p.
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 4, Pp 716-727 (2024)
Abstract Aim Real‐world data (RWD) for paliperidone palmitate (PP) three‐monthly (PP3M) is lacking based on Japan label requirements. This study evaluated the clinical effectiveness of PP3M versus PP once‐monthly (PP1M) in patients with schizop
Externí odkaz:
https://doaj.org/article/f52aacf1f0b84781a93882a3e6273d85
Autor:
García-Carmona JA, Pappa S
Publikováno v:
Drug, Healthcare and Patient Safety, Vol Volume 15, Pp 113-123 (2023)
Juan Antonio García-Carmona,1– 3 Sofia Pappa4,5 1Department of Neurology, Santa Lucia University Hospital, Cartagena, Murcia, Spain; 2Unit of Acute Psychiatry, Reina Sofía University Hospital, Murcia, Spain; 3Group of Clinical and Experimental Ph
Externí odkaz:
https://doaj.org/article/cd714793108946a89db86905337f077a
Autor:
A. S. Pareja Zea, C. Vera-Varela, A. Martínez Martínez, G. García Jimenez, M. De Iceta Ibañez de Gauna
Publikováno v:
European Psychiatry, Vol 67, Pp S727-S727 (2024)
Introduction The treatment of patients with severe psychotic disorders presents significant clinical challenges, and the choice of appropriate therapy is essential to ensure long-term stability1. In this context, long-acting injectable antipsychotic
Externí odkaz:
https://doaj.org/article/57217dd9a465499284ab8352e8500b8e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Psychiatry, Vol 67 (2024)
Abstract Background Paliperidone palmitate 3-monthly (PP3M) has been tested in 1-year controlled studies. The aim of this study was to examine the relapse outcomes with PP3M monotherapy at 3 years in patients with schizophrenia. Methods This was a
Externí odkaz:
https://doaj.org/article/4346304531ff44cebf71740ac366db2b
Autor:
Katalin Pungor, Pedro Sanchez, Sofia Pappa, Jerome Attal, Karolina Leopold, Geertje Steegen, Antonio Vita, Carol Marsella, Caroline Verrijcken, Marjolein Lahaye, Annette Wooller
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background To understand the implications of switching from paliperidone palmitate 1-monthly (PP1M) to paliperidone palmitate 3-monthly (PP3M) treatment of schizophrenia from the perspective of four key stakeholders: patients, physicians, nu
Externí odkaz:
https://doaj.org/article/57e63c84a17d410db14ac91b3e7237cf
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 1365-1379 (2019)
Maju Mathews,1 Srihari Gopal,1 Isaac Nuamah,1 Ludger Hargarter,2 Adam J Savitz,1 Edward Kim,3 Wilson Tan,4 Bernardo Soares,5 Christoph U Correll6–81Department of Neuroscience, Janssen Research & Development, LLC, Raritan, NJ, USA; 2Department of Ne
Externí odkaz:
https://doaj.org/article/b81367fbed5e43a5b09a55d1a775e7bc
Autor:
Di Lorenzo R, Iorio A, Pinelli M, Magarini F, Marchi M, Sacchetti A, Calogero C, Galeazzi GM, Ferri P, Rovesti S, Minarini A
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 18, Pp 829-846 (2022)
Rosaria Di Lorenzo,1 Anita Iorio,2 Margherita Pinelli,3 Federica Magarini,3 Mattia Marchi,3 Andrea Sacchetti,3 Chiara Calogero,4 Gian Maria Galeazzi,5 Paola Ferri,5 Sergio Rovesti,5 Alessandro Minarini6 1Service of Psychiatric Diagnosis and Care, Dep
Externí odkaz:
https://doaj.org/article/8bc1138ad5d446cfbf11f7a61f3adc15